Presentation TCT 2017 Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials Presenter: Bernard J. Gersh, Michel Ovize October 31, 2017
Presentation TCT 2017 The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial Presenter: Bernard R. Chevalier, Corrado Tamburino, Kai Xu October 31, 2017
Presentation TCT 2017 Imaging Infarct Size and Reperfusion Injury: State-of-the-Art Presenter: Bernard J. Gersh, Michel Ovize, Suzanne de Waha October 31, 2017
Presentation TCT 2017 Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds Presenter: Bernard R. Chevalier, Corrado Tamburino, Ron Waksman October 31, 2017
Presentation TCT 2017 Case Presentation: Biventricular Collapse in STEMI With Shock Presenter: Michael Mooney, Holger Thiele, Vladimir Dzavik October 31, 2017
Presentation TCT 2017 Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA Presenter: Bernard R. Chevalier, Corrado Tamburino, Juan F. Granada October 31, 2017
Presentation TCT 2017 Hemodynamic Support for Acute RV Failure: Impella, TandemHeart, or ECMO? Presenter: Michael Mooney, Holger Thiele, Danny Ramzy October 31, 2017
Presentation TCT 2017 Right Ventricular Failure in Cardiogenic Shock: When to Suspect, How to Diagnose Presenter: Michael Mooney, Holger Thiele, Marwan F. Jumean October 31, 2017
Presentation TCT 2017 Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics Presenter: Bernard R. Chevalier, Corrado Tamburino, James B. Hermiller Jr. October 31, 2017
Presentation TCT 2017 Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye October 31, 2017
Presentation TCT 2017 DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used Selectively! Presenter: Michael Mooney, Holger Thiele, Jose P.S. Henriques October 31, 2017
Presentation TCT 2017 Percutaneous Mechanical Support Devices: Current Uses and Unmet Clinical Needs Presenter: David E. Kandzari, Jaime Raben, John C Laschinger October 31, 2017
Presentation TCT 2017 Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma October 31, 2017
Presentation TCT 2017 DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used in All Patients! Presenter: Michael Mooney, Holger Thiele, Tanveer Rab October 31, 2017
Presentation TCT 2017 Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned Presenter: David E. Kandzari, Jaime Raben October 31, 2017
Presentation TCT 2017 Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry Presenter: Michael Mooney, Holger Thiele, Brian P O'Neill October 31, 2017
Presentation TCT 2017 Mechanical Hemodynamic Support: Counterpulsation, Rotary Flow, or ECMO for Cardiogenic Shock, and Why? Presenter: Michael Mooney, Holger Thiele, Navin K. Kapur October 31, 2017
Presentation TCT 2017 Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples) Presenter: David Hildick-Smith, Jeffrey W. Moses, Carlo Briguori October 31, 2017
Presentation TCT 2017 Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra October 31, 2017
Presentation TCT 2017 Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne October 31, 2017